跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maedicoxib - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Maedicoxib
Approved
STANDARD
Maedicoxib
Lifesquare Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6277860412196cfd
Company
Lifesquare Laboratories Inc
Type
Standard
Approval Details
Approval Id
6277860412196cfd
Drug Approval Philippines Name
Maedicoxib
Product Name
Maedicoxib
Registration Number
DRP-5020-03
Brand Name
Maedicoxib
Generic Name
Celecoxib
Dosage Form
Capsule
Dosage Strength
400 mg
Manufacturer
Lifesquare Laboratories Inc
Distributor
Maed Pharma Corporation
Issuance Date
25 July 2024
Expiry Date
22 September 2026
Pharmacologic Category
Selective COX-2 Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6277860412196cfd
Type
Standard
Back to Philippines FDA Approvals